Analysis of the results of the use of endovascular technologies in the treatment of patients with type 2 diabetes mellitus complicated by diabetic foot syndrome

Introduction. Revascularization for the neuroischemic form of diabetic foot syndrome is associated with difficulties in vascular reconstruction and a difficult postoperative course, due to the severe comorbidities in this patient population. Therefore, endovascular treatment of diabetic foot syndrome is rapidly becoming the treatment of choice for these patients, as lower extremity ischemia is a significant determinant of their mortality. The purpose of the study. To analyze the results of revascularization interventions in the neuro-ischemic form of diabetic foot syndrome and identify ways to improve these results. Materials and methods. The prospective study included 93 patients with ulcerative necrotic lesions of the feet and lower leg on the background of critical ischemia in the neuro-ischemic form of diabetic foot syndrome. The duration of diabetes mellitus in patients ranged from 1 month (diagnosed during examination for ulcerative necrotic lesions of the feet) to 41 years, the median was 12 years (the 25th percentile is 8 years, the 75th percentile is 20 years). Research results and discussion. Successful treatment of patients with ulcerative necrotic foot lesions in the neuro-ischemic form of diabetic foot syndrome is possible in centers where conditions are available for angiographic examination, endovascular interventions, and vascular angioreconstructions. A multidisciplinary team with a wide range of possibilities for limb revascularization and wound treatment is the main factor in the successful treatment of patients with the neuro-ischemic form of diabetic foot syndrome. Conclusion. The development of early diagnosis methods (before ulcerative necrotic foot lesions) and timely revascularization are promising areas for improving care for patients with the neuro-ischemic form of diabetic foot syndrome.